EUVIMEDEUVIMED entdecken
Crossref

Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κ B Signaling Pathway

Quan Li, Juan Chen, Meng-Meng Wang, Li-Ping Cao, Wei Zhang, Zhi-Zhou Yang, Yi Ren, Jing Feng, Xiao-Qin Han, Shi-Nan Nie, Zhao-Rui Sun

Chinese Journal of Integrative Medicine · 2025

DOI: 10.1007/s11655-024-3769-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, 2025. Verfasst von Quan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Suqian First Hospital, Suqian, Jiangsu Province, 223800, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Respiratory Distress Syndrome, p38 Mitogen-Activated Protein Kinases, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To explore the potential effects and mechanisms of Liang-Ge-San (LGS) for the treatment of acute respiratory distress syndrome (ARDS) through network pharmacology analysis and to verify LGS activity through biological experiments. METHODS: The key ingredients of LGS and related targets were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. ARDS-related targets were selected from GeneCards and DisGeNET databases. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed using the Metascape Database. Molecular docking analysis was used to confirm the binding affinity of the core compounds with key therapeutic targets. Finally, the effects of LGS on key signaling pathways and biological processes were determined by in vitro and in vivo experiments. RESULTS: A total of LGS-related targets and 496 ARDS-related targets were obtained from the databases. Network pharmacological analysis suggested that LGS could treat ARDS based on the following information: LGS ingredients luteolin, wogonin, and baicalein may be potential candidate agents. Mitogen-activated protein kinase 14 (MAPK14), recombinant V-Rel reticuloendotheliosis viral oncogene homolog A (RELA), and tumor necrosis factor alpha (TNF-α) may be potential therapeutic targets. Reactive oxygen species metabolic process and the apoptotic signaling pathway were the main biological processes. The p38MAPK/NF-κ B signaling pathway might be the key signaling pathway activated by LGS against ARDS. Moreover, molecular docking demonstrated that luteolin, wogonin, and baicalein had a good binding affinity with MAPK14, RELA, and TNF α. In vitro experiments, LGS inhibited the expression and entry of p38 and p65 into the nucleation in human bronchial epithelial cells (HBE) cells induced by LPS, inhibited the inflammatory response and oxidative stress response, and inhibited HBE cell apoptosis (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalRespiratory Distress Syndromep38 Mitogen-Activated Protein KinasesNF-kappa BSignal TransductionAnimalsMolecular Docking SimulationHumansMaleNetwork PharmacologyApoptosisMice

Stichwörter der Autor:innen

Liang-Ge-Sanacute respiratory distress syndromeanimal experimentsmolecular dockingnetwork pharmacology

Substanzen

Drugs, Chinese Herbalp38 Mitogen-Activated Protein KinasesNF-kappa B

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Suqian First Hospital, Suqian, Jiangsu Province, 223800, China.
  • Department of Emergency Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China.
  • Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Emergency Medicine, the First School of Clinical Medicine, Southern Medical University, Nanjing, 210002, China.
  • Department of Emergency Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China. sunzhr84@163.com.
  • Nanjing University of Chinese Medicine, Nanjing, 210023, China. sunzhr84@163.com.

Zitieren

APA

Li, Q., Chen, J., Wang, M. M., Cao, L. P., Zhang, W., Yang, Z. Z., Ren, Y., Feng, J., Han, X. Q., Nie, S. N., & Sun, Z. R. (2025). Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κ B Signaling Pathway. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-3769-6

Vancouver

Li Q, Chen J, Wang MM, Cao LP, Zhang W, Yang ZZ, et al. Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κ B Signaling Pathway. Chinese Journal of Integrative Medicine. 2025. doi:10.1007/s11655-024-3769-6

BibTeX
@article{Li2025,
  author = {Li, Quan and Chen, Juan and Wang, Meng-Meng and Cao, Li-Ping and Zhang, Wei and Yang, Zhi-Zhou and Ren, Yi and Feng, Jing and Han, Xiao-Qin and Nie, Shi-Nan and Sun, Zhao-Rui},
  title = {Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κ B Signaling Pathway},
  journal = {Chinese Journal of Integrative Medicine},
  year = {2025},
  doi = {10.1007/s11655-024-3769-6}
}
Kostenlos starten →